Phoenix Urology of St. Joseph Honored as Fifth Practice Nationwide To Have Two Physicians Designated as UroLift Center of Excellence

Thursday, April 12, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Designation Recognizes Drs. Mike Kozminski and Bradley Moore's Commitment to Exemplary Care, Deep UroLift Experience in Men with Enlarged Prostate

ST. JOSEPH, Mo., April 12, 2018 /PRNewswire-PRWeb/ -- Phoenix Urology of St. Joseph

today announced that Drs. Mike Kozminski and Bradley Moore have been designated as UroLift® Centers of Excellence. The designation recognizes that Dr. Kozminski and Dr. Moore have demonstrated a commitment to exemplary care for men suffering from urinary tract symptoms due to benign prostatic hyperplasia (BPH) and have achieved a high level of training and experience with the UroLift System. Phoenix Urology of St. Joseph is one of only five practices in the U.S. to have two physicians within the same practice earn this distinction.

"The UroLift System is a breakthrough minimally invasive treatment that takes less than an hour and offers multiple benefits for men with enlarged prostate – no cutting, heating, or removal of tissue, minimal downtime, no compromise of sexual function, and no need for continued medications," said Dr. Kozminski. "UroLift has fundamentally changed how we treat patients suffering bothersome BPH symptoms. We are proud to be national leaders in treating patients with this durable and effective treatment," added Dr. Moore.

Nearly 40 million men in the United States are affected by BPH. This condition occurs as the prostate gland that surrounds the male urethra becomes enlarged, exerting pressure on the urethra and restricting or blocking urine flow. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life.

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.

Medications can be helpful in relieving symptoms for some men, but patients must continue taking them long-term to maintain the effects. Some patients may suffer side effects including dizziness, headaches, or sexual dysfunction. And some may not get adequate relief of their symptoms. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.

About the UroLift System NeoTract Interventional Urology's FDA-cleared UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About Phoenix Urology of St. Joseph Phoenix Urology serves the urological needs of St. Joseph, Missouri and surrounding areas. Urologists Michael E. Aberger, M.D.; Mike Kozminski, M.D., F.A.C.S.; Mark F. Lierz, M.D. and Bradley J. Moore, M.D. have helped thousands of people discuss and deal with their most personal health problems offering compassionate, personalized care in a safe and confidential environment. Phoenix Urology is independently owned and operated and has several clinics located in the surrounding areas of St. Joseph, Missouri.

# # #

Media Contact: Amy Cramer 650-391-3714 amy(at)healthandcommerce.com

 

SOURCE NeoTract



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store